Načítá se...
Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutrophil cytoplasmic antibody (ANCA) associated vascul...
Uloženo v:
| Vydáno v: | J Bras Nefrol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sociedade Brasileira de Nefrologia
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533989/ https://ncbi.nlm.nih.gov/pubmed/29738027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-3858 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|